1KAM K M,WAI Lin-leung,KA Hing-wong,et al.Maturational Changes in Peripheral Lymphocyte Subsets Pertinent to Monitoring Human Immunodeficiency Virus-Infected Chinese Pediatric Patients[J].Clinical and diagnostic laboratory immunology,2001,8(5):926-931.
2SHAHABUDEDIN S,Al-AYED I,GAD El-RAB M O,et al.Age-Related Changes in Blood Lymphocyte Subsets of Saudi Arabian Healthy Children[J].Clin Diagn Lab Immunol,1998,5(5):632-635.
3ORGANIZATION W H.WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classiftcation of HIV-related Disease in Adults and Children[M].Geneva:WHO Press August,2006:7.
4DENNY T,YOGEV R,REBECCA M D,et al.Lymphocyte Subsets in Healthy Children During the First 5 Years of Life.[J]JAMA,1992,267(11):1484-1488.
5ABRAMS E J,WEEDON J,RICHARD W,et al.Association of human immunodeficiency virus(HIV)load early in life with disease progression among HIV-infected infants.[J]J Infect Dis,1998,178:101-108.
6TAHAA T,KUMWENDAA N I,DONALD R,et al.Association of HIV-1 load and CD4 lymphocyte count with mortality among untreated African children over one year of age.[J]AIDS,2000,14:453-459.
7LESLIE A,MCLNTOSH K K,JENNIFER S,et al.Evaluation of human immunodeficiency virus(HIV)type 1 load,CD4 T cell level,and clinical class as time-fixed and time-varying markers of disease progression in HIV-1-Infected children.[J]J Infect Dis,1999,180:1514-1520.
8LUZURIAGA K,MCMANUS M,CATALINA M,et al.Early therapy of vertical human imrnunodeficiency type 1(HIV-1)infection:control of viral replication and absence of persistent HIV-1-specific immune responses.[J]J Virol,2000,74:6984-6991.
9VIOLARI A,PAED F C,MARK F,et al.Early antiretroviral therapy and mortality among HIV-Infected infants[J].N Engl J Med,2008,20:2233-2244.
10U. S. Public Health Service(USPHS) and Infectious Disease Society of America( IDSA). 2001 USPHA/IDSA guidelines for the prevention of opportunistic infected with human immunodeficiency virus [ J ].MMWR,2001,1 - 68.
8Wang H, Nishanian P, Fahey JL. Characterization of immune sup-pression by a synthetic HIV gp41 peptide[ J]. Cell Immunol, 1995,161(2): 236 - 243.
9Carr6 N,Boufassa F,Hubert JB,et al. Predictive value of viral loadand other markers for progression to clinical AIDS after CD4 + cellcount falls below 200/microL. SEROCO & HEMOCO Study Group[J]. Int J Epidemiol, 1998,27(5) : 897 - 903.
10Paul ME, Shearer WT, Kozinetz CA, et al. Comparison of CD8 +Tcell subsets in HIV-infected rapid progressor children versus non-rapid progressor children [ J ]. J Allergy Clin Immunol, 2001,108(2): 258-264.
